Personal information

No personal information available

Activities

Employment (2)

Cancer Research UK Manchester Institute: Manchester, Manchester, GB

2017-05-08 to present | Postdoctoral Researcher (Molecular Oncology)
Employment
Source: Self-asserted source
Pauline HASCOET

Institute of Genetic and Development of Rennes: Rennes, FR

2012-10-01 to 2016-04-29 | PhD student
Employment
Source: Self-asserted source
Pauline HASCOET

Works (4)

MiR-378a inhibits glucose metabolism by suppressing GLUT1 in prostate cancer

Oncogene
2022-03-04 | Journal article
Contributors: A. Cannistraci; P. Hascoet; A. Ali; P. Mundra; N. W. Clarke; V. Pavet; R. Marais
Source: check_circle
Crossref

The prefoldin complex stabilizes the von Hippel-Lindau protein against aggregation and degradation

PLOS Genetics
2020-11-02 | Journal article
Part of ISSN: 1553-7404
Source: Self-asserted source
Pauline HASCOET
grade
Preferred source (of 2)‎

The pVHL172 isoform is not a tumor suppressor and up-regulates a subset of pro-tumorigenic genes including TGFB1 and MMP13.

Oncotarget
2017-06-06 | Journal article
Source: Self-asserted source
Pauline HASCOET

The von Hippel-Lindau tumour suppressor gene: uncovering the expression of the pVHL172 isoform.

British journal of cancer
2015-06-02 | Journal article
Source: Self-asserted source
Pauline HASCOET